Herbal granules aim to ease kidney side effect of lung cancer drugs

NCT ID NCT07358520

First seen Jan 25, 2026 · Last updated Apr 30, 2026 · Updated 13 times

Summary

This study tests whether Huaier Granules, a traditional Chinese medicine, can reduce protein in the urine (proteinuria) caused by the cancer drugs Bevacizumab or Anlotinib in lung cancer patients. About 40 adults will take the granules for 16 weeks to see if their protein levels improve. The goal is to manage this side effect and help patients stay on their cancer treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROTEINURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xuzhou Central Hospital

    Xuzhou, Jiangsu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.